gptkbp:instance_of
|
gptkb:motorcycle
|
gptkbp:bfsLayer
|
3
|
gptkbp:bfsParent
|
gptkb:motorcycle
|
gptkbp:affects
|
gptkb:skincare_product
connective tissue
|
gptkbp:caused_by
|
autoimmune response
|
gptkbp:clinical_trial
|
stem cell therapy
biologics
new therapies
|
gptkbp:color
|
gptkb:blue
|
gptkbp:complications
|
pulmonary hypertension
interstitial lung disease
esophageal dysfunction
renal crisis
|
gptkbp:current_use
|
gptkb:healthcare_organization
gptkb:rheumatoid_arthritis
thyroid disease
|
gptkbp:environmental_impact
|
silica exposure
solvent exposure
|
gptkbp:genetic_diversity
|
family history
specific gene mutations
|
gptkbp:historical_figure
|
gptkb:Miriam_Makeba
gptkb:Paul_Klee
|
https://www.w3.org/2000/01/rdf-schema#label
|
systemic scleroderma
|
gptkbp:is_involved_in
|
gptkb:Scleroderma_Foundation
Scleroderma Research Foundation
|
gptkbp:is_popular_in
|
more common in women
|
gptkbp:notable_event
|
gptkb:Marlon_Brando
gptkb:Maya_Angelou
gptkb:The_Joan_Rivers
|
gptkbp:premiered_on
|
30 to 50 years
|
gptkbp:public_awareness
|
gptkb:June
|
gptkbp:research_focus
|
quality of life
treatment options
pathogenesis
|
gptkbp:social_responsibility
|
blood tests
skin biopsy
|
gptkbp:symptoms
|
gptkb:Raynaud's_phenomenon
fatigue
joint pain
shortness of breath
thickening of the skin
|
gptkbp:treatment
|
physical therapy
corticosteroids
immunosuppressants
|